Showing 1 - 6 results of 6 for search 'Hongxing Pan', query time: 0.04s Refine Results
  1. 1
    Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China

    Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical t... by Yang Zhang, Shiyuan Wang, Guifan Li, Jinhui Shi, Xianyun Chang, Hao Zhang, Fengcai Zhu, Jingxin Li, Hongxing Pan, Jinfang Sun

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial

    Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled p... by Aihua Yao, Siyue Jia, Xin Cheng, Hongxing Pan, Zhijian Wang, Haitao Yang, Yu Xia, Jianfang Xu, Xuefen Huai, Danjing Leng, Ming Xu, Jiarong Wang, Gan Zhao, Bin Wang, Jingxin Li

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Factors Influencing the Incidence, Persistence, and Severity of Symptoms After SARS-CoV-2 Infection in Chinese Adults: A Case–Control Study

    The Factors Influencing the Incidence, Persistence, and Severity of Symptoms After SARS-CoV-2 Infection in Chinese Adults: A Case–Control Study by Weixiao Wang, Runjie Qi, Siyue Jia, Zhihang Peng, Hongxing Pan, Ming Xu, Yuanbao Liu, Xiaoqiang Liu, Qing Wang, Li Zhang, Jihai Tang, Hao Yang, Pengfei Jin, Simin Li, Jingxin Li

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years

    A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years by Kai Chu, Jiali Quan, Xiaohui Liu, Qi Chen, Xia Zang, Hanmin Jiang, Donglin Liu, Xiafei Chu, Chunlan Zhuang, Jinle Han, Xiangzhong Ye, Hongxing Pan, Shoujie Huang, Ting Wu, Jun Zhang, Ningshao Xia

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China

    Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China by Siyue Jia, Yuanbao Liu, Qian He, Hongxing Pan, Zhenglun Liang, Juan Zhou, Yingzi Pan, Sheng Liu, Jingjing Wu, Kun Yang, Xuanxuan Zhang, Yang Zhao, Simin Li, Lei Zhang, Li Chen, Aihua Yao, Mengyi Lu, Fengcai Zhu, Qunying Mao, Jingxin Li

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial

    Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a random... by Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Haitao Huang, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin Chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Wei Chen, Jingxin Li, Fengcai Zhu

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: